Foghorn Therapeutics Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $195.4M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.2M | 0.6% |
| Other Investing | $194.2M | 99.4% |
Net Cash Flow Breakdown
Total Cash from Operations: $195.4M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $1.2M | 0.6% |
| Other Investing | $194.2M | 99.4% |